LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.63 | 27.76 | 3 | 4818 | 0.0006 | -0.2585 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.63 | 27.76 | 546 | 4818 | 0.1133 | 0.4925 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.63 | 27.76 | 1 | 4818 | 0.0002 | -0.3603 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.63 | 27.76 | 1 | 4818 | 0.0002 | -0.3603 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.33 | 27.76 | 4 | 5117 | 0.0008 | -0.2269 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.33 | 27.76 | 518 | 5117 | 0.1012 | 0.4753 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.33 | 27.76 | 1 | 5117 | 0.0002 | -0.3570 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.33 | 27.76 | 1 | 5117 | 0.0002 | -0.3570 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.04 | 27.76 | 1 | 5365 | 0.0002 | -0.3544 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.04 | 27.76 | 495 | 5365 | 0.0923 | 0.4613 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.04 | 27.76 | 1 | 5365 | 0.0002 | -0.3544 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.04 | 27.76 | 1 | 5365 | 0.0002 | -0.3544 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.74 | 27.76 | 1 | 5606 | 0.0002 | -0.3521 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.74 | 27.76 | 366 | 5606 | 0.0653 | 0.4004 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.74 | 27.76 | 1 | 5606 | 0.0002 | -0.3521 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.74 | 27.76 | 1 | 5606 | 0.0002 | -0.3521 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 56.45 | 27.76 | 1 | 5745 | 0.0002 | -0.3508 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 56.45 | 27.76 | 371 | 5745 | 0.0646 | 0.4007 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 56.45 | 27.76 | 1 | 5745 | 0.0002 | -0.3508 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 56.45 | 27.76 | 1 | 5745 | 0.0002 | -0.3508 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.15 | 27.76 | 1 | 5906 | 0.0002 | -0.3493 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.15 | 27.76 | 337 | 5906 | 0.0571 | 0.3810 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.15 | 27.76 | 1 | 5906 | 0.0002 | -0.3493 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.15 | 27.76 | 1 | 5906 | 0.0002 | -0.3493 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 59.85 | 27.76 | 1 | 6062 | 0.0002 | -0.3480 | MN20160318_Q01 | D13 |